XERS - Xeris Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts4244
Avg. Estimate-1.07-0.8-4.65-3.05
Low Estimate-1.24-0.84-4.84-3.68
High Estimate-0.83-0.76-4.41-2.38
Year Ago EPS-0.98-1.07-4.99-4.65
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts4244
Avg. Estimate1.3M3.24M2.11M23.76M
Low Estimate810k2.99M1.45M22.17M
High Estimate2.2M3.5M3.1M26.7M
Year Ago Sales801k248k2.46M2.11M
Sales Growth (year/est)62.30%1,206.50%-14.40%1,026.10%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.93-0.76-0.94-1.23
EPS Actual-0.98-1.07-1.28-1.22
Difference-0.05-0.31-0.340.01
Surprise %-5.40%-40.80%-36.20%0.80%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-1.07-0.8-4.65-3.05
7 Days Ago-1.07-0.8-4.65-3.05
30 Days Ago-1.07-0.8-4.65-3.05
60 Days Ago-1.07-0.8-4.65-3.05
90 Days Ago-1.05-0.77-4.63-3.14
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesXERSIndustrySectorS&P 500
Current Qtr.-9.20%N/AN/A0.01
Next Qtr.25.20%N/AN/A0.06
Current Year6.80%N/AN/A-0.02
Next Year34.40%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A